Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Shanghai Junshi Biosciences Co., Ltd. has announced the composition of its Board of Directors, which includes executive, non-executive, and independent non-executive members, chaired by Mr. Xiong Jun. The Board has formed four committees—Audit, Nomination, Remuneration and Appraisal, and Strategic—with designated chairs and members from the Board.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.